Table 2 Comparison of laboratory indexes between early-onset group and late-onset group
All (n = 64) | Early-onset group (n = 32) | Late-onset group (n = 32) | t/Z | P | |
|---|---|---|---|---|---|
Peripheral blood | |||||
WBC, (109/L), Mean ± SD | 8.00 ± 2.29 | 8.25 ± 2.13 | 7.75 ± 2.46 | 0.860 | 0.393 |
Neu, (109/L), Mean ± SD | 5.30 ± 2.38 | 5.80 ± 2.17 | 5.02 ± 2.57 | 0.951 | 0.345 |
Eos%, (%), Median (Q1, Q3) | 2.2 (0.2, 7.5) | 1.0 (0.2, 7.3) | 3.7 (0.2, 7.5) | 1.717 | 0.241 |
Eos, (109/L), Median (Q1, Q3) | 0.22 (0.02, 0.53) | 0.07 (0.01, 0.53) | 0.28 (0.03, 0.53) | 1.124 | 0.261 |
Neu/Eos, Median (Q1, Q3) | 15.48 (6.79, 82.25) | 24.92 (6.94, 131.91) | 12.19 (6.05, 54.24) | 0.737 | 0.461 |
IL-5, (ng/L), Median (Q1, Q3) | 87.28 (35.79, 108.2) | 89.54 (37.94, 104.34) | 87.16 (29.49, 111.68) | 0.156 | 0.876 |
IL-17, (ng/L), Median (Q1, Q3) | 51.10 (40.25,81.98) | 52.96 (47.99,105.50) | 44.75 (20.81, 54.99) | 2.400 | 0.016* |
HVEM, (pg/L), Median (Q1, Q3) | 87.23 (54.19, 109.2) | 84.18 (57.21, 95.01) | 94.75 (43.81, 115.69) | 0.782 | 0.434 |
Induced sputum | |||||
Neu%, (%), Mean ± SD | 60.98 ± 28.68 | 72.04 ± 26.90 | 53.61 ± 27.89 | 2.202 | 0.033* |
Eos%, (%), Median (Q1, Q3) | 12.45 (1.40, 32.35) | 3.8 (1.4, 14.4) | 13.4 (2.8, 39.2) | 1.490 | 0.136 |
Neu%/Eos%, Median (Q1, Q3) | 5.99 (1.14, 48.40) | 12.60 (3.23, 63.74) | 2.62 (1.00, 23.25) | 1.219 | 0.223 |
FeNO, (ppb), Median (Q1, Q3) | 27.0 (16.0, 49.5) | 22.5 (16.0, 47.3) | 32.5 (16.0, 50.3) | 0.559 | 0.576 |